KLK3 and posterior cortical atrophy: BCR-PCa represents a state of recurrent disease characterized by rising PSA levels post-local therapy without metastatic disease that is detectable on conventional imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), or bone scans.